This miRNA targets Insulin receptor, Insulin Receptor Substrate-2, and Insulin Degrading Enzyme, which are critical to glucose homeostasis and Aβ metabolism in AD (Fernández-de Frutos et al., 2019). This evidence concerns the gene IRS2 and Alzheimer disease.